Author

C. Ménard

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Stereotactic Body Radiotherapy vs. Moderately Hypofractionated IMRT for Localized Intermediate Risk Prostate Cancer: A Randomized Clinical Trial

Importance The treatment of prostate cancer with radiotherapy is evolving. How quickly radiotherapy can be delivered, and the relative risks and benefits of such a treatment, is of significant public interest. Objective To determine whether stereotactic body radiotherapy (SBRT) was superior to moderately-hypofractionat...

R. J. Ellis, S. L. Pugh, James B. Yu et al. · Journal of the American Medi... · 2 citations

Review Open access Sep 2026

Theranostics for prostate cancer: A Canadian, multidisciplinary expert report

Introduction: Prostate-specific membrane antigen (PSMA) positron emission tomography/computed tomography (PET/CT) and PSMA radioligand therapy are changing prostate cancer management, but there is ongoing uncertainty regarding how best to incorporate these approaches into routine practice. This expert report provides C...

A. Lalani, Mina M. Swiha, Sharlini Yogasingam et al. · Canadian Urological Associat... · 0 citations